News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,564 Results
Type
Article (40702)
Company Profile (297)
Press Release (668565)
Multimedia
Podcasts (77)
Webinars (12)
Section
Business (207107)
Career Advice (2073)
Deals (35878)
Drug Delivery (100)
Drug Development (82401)
Employer Resources (176)
FDA (16266)
Job Trends (15179)
News (350160)
Policy (32879)
Tag
Academia (2574)
Accelerated approval (5)
Adcomms (20)
Allergies (87)
Alliances (50248)
ALS (97)
Alzheimer's disease (1408)
Antibody-drug conjugate (ADC) (139)
Approvals (16260)
Artificial intelligence (268)
Autoimmune disease (22)
Automation (17)
Bankruptcy (363)
Best Places to Work (11757)
BIOSECURE Act (21)
Biosimilars (109)
Biotechnology (212)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (294)
Cancer (2335)
Cardiovascular disease (185)
Career advice (1730)
Career pathing (33)
CAR-T (156)
Cell therapy (442)
Cervical cancer (20)
Clinical research (67146)
Collaboration (871)
Company closure (2)
Compensation (573)
Complete response letters (21)
COVID-19 (2615)
CRISPR (41)
C-suite (257)
Cystic fibrosis (103)
Data (2340)
Decentralized trials (2)
Denatured (27)
Depression (48)
Diabetes (276)
Diagnostics (6399)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (120)
Drug pricing (107)
Drug shortages (25)
Duchenne muscular dystrophy (98)
Earnings (88063)
Editorial (45)
Employer branding (23)
Employer resources (150)
Events (115095)
Executive appointments (757)
FDA (17651)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (770)
Gene editing (111)
Generative AI (21)
Gene therapy (319)
GLP-1 (749)
Government (4477)
Grass and pollen (5)
Guidances (158)
Healthcare (18904)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (124)
Indications (30)
Infectious disease (2760)
Inflammatory bowel disease (145)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (99)
Interviews (329)
IPO (16763)
IRA (41)
Job creations (3840)
Job search strategy (1469)
Kidney cancer (10)
Labor market (43)
Layoffs (491)
Leadership (22)
Legal (7960)
Liver cancer (76)
Lung cancer (326)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (329)
MASH (81)
Medical device (13400)
Medtech (13405)
Mergers & acquisitions (19694)
Metabolic disorders (723)
Multiple sclerosis (85)
NASH (16)
Neurodegenerative disease (97)
Neuropsychiatric disorders (29)
Neuroscience (1977)
NextGen: Class of 2025 (6571)
Non-profit (4499)
Now hiring (41)
Obesity (380)
Opinion (223)
Ovarian cancer (82)
Pain (93)
Pancreatic cancer (88)
Parkinson's disease (154)
Partnered (22)
Patents (246)
Patient recruitment (116)
Peanut (46)
People (58212)
Pharmaceutical (76)
Pharmacy benefit managers (20)
Phase I (20959)
Phase II (29636)
Phase III (21948)
Pipeline (1376)
Policy (158)
Postmarket research (2573)
Preclinical (8909)
Press Release (64)
Prostate cancer (109)
Psychedelics (31)
Radiopharmaceuticals (257)
Rare diseases (386)
Real estate (6031)
Recruiting (67)
Regulatory (22590)
Reports (47)
Research institute (2343)
Resumes & cover letters (354)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (74)
Series A (131)
Series B (87)
Service/supplier (11)
Sickle cell disease (52)
Special edition (18)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3662)
State (2)
Stomach cancer (13)
Supply chain (70)
Tariffs (53)
The Weekly (48)
Vaccines (716)
Venture capitalists (43)
Weight loss (246)
Women's health (39)
Worklife (20)
Date
Today (174)
Last 7 days (983)
Last 30 days (3131)
Last 365 days (32941)
2025 (11995)
2024 (35730)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35385)
2017 (32635)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29670)
2010 (27706)
Location
Africa (741)
Alabama (59)
Alaska (7)
Arizona (235)
Arkansas (14)
Asia (39187)
Australia (6332)
California (6444)
Canada (2074)
China (559)
Colorado (277)
Connecticut (283)
Delaware (160)
Europe (84669)
Florida (967)
Georgia (215)
Idaho (57)
Illinois (550)
India (25)
Indiana (325)
Iowa (11)
Japan (172)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (936)
Massachusetts (4826)
Michigan (225)
Minnesota (407)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1810)
New Mexico (29)
New York (1815)
North Carolina (1044)
North Dakota (8)
Northern California (2833)
Ohio (211)
Oklahoma (14)
Oregon (35)
Pennsylvania (1431)
Puerto Rico (14)
Rhode Island (33)
South America (1122)
South Carolina (25)
South Dakota (1)
Southern California (2421)
Tennessee (105)
Texas (960)
United States (24263)
Utah (189)
Virginia (154)
Washington D.C. (65)
Washington State (574)
West Virginia (3)
Wisconsin (56)
709,564 Results for "akeso biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
Summit, Akeso’s Keytruda Challenger Wins Chinese OK as US Approval Questions Linger
With ivonescimab’s data coming solely from China, its prospects in the U.S., where Summit owns the rights, remain up in the air.
April 28, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Akeso’s 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies
March 31, 2025
·
11 min read
Press Releases
Akeso Announces FDA Approval for Penpulimab-kcqx in Two BLA Indications for Comprehensive Treatment of Advanced Nasopharyngeal Carcinoma
April 25, 2025
·
6 min read
Press Releases
Akeso Biopharma to Attend Jefferies London Healthcare Conference and Morgan Stanley 23rd Asia Pacific Summit
November 18, 2024
·
5 min read
Press Releases
Akeso Received Payment for the Development Collaboration on Tagitanlimab
January 22, 2025
·
1 min read
Press Releases
Akeso’s Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis
April 21, 2025
·
5 min read
Press Releases
Akeso’s Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
March 17, 2025
·
3 min read
Press Releases
Akeso to Host 2024 Full-Year Financial Results and Corporate Update Call on Monday, March 31, 2025
March 28, 2025
·
2 min read
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
May 1, 2025
·
1 min read
·
Angela Gabriel
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in Massachusetts impacted around 410 people, based on
BioSpace
estimates. Meanwhile, competition for jobs in those states increased year over year, according to
BioSpace
data.
April 17, 2025
·
5 min read
·
Angela Gabriel
1 of 70,957
Next
